Methods for Estimating ALS Heritability Reviewed in New Report
A group of researchers from the King’s College London recently published a new editorial entitled, “Heritability of Amyotrophic…
Articles by Margarida Azevedo, MSc
SciFluor Granted U.S. Patent for KCNQ2/3 Activator to Treat ALS and Epilepsy
The U.S. Patent and Trademark Office (USPTO) recently granted clinical stage biopharmaceutical company and subsidiary of Allied Minds, SciFluor Life…
ALS Muscle Biopsies Exhibit Chronic Neurogenic Atrophy, Study Shows
Recent evidence shows that in amyotrophic lateral sclerosis (ALS), there occurs a notable deposition of abnormal ubiquitinated inclusions immunoreactive to TDP-43. In order…
‘Quality of Life’ Underrated in Evaluating ALS Treatment Efficacy
A recent review, entitled, “Patient-Perceived Outcomes and Quality of Life in ALS”, which was published…
Hair Analysis of Japanese ALS Patients Reveal Trace Metals that May Increase Disease Risk
The accumulation of specific metals may trigger neuronal degeneration associated with Amyotrophic lateral sclerosis (ALS), according…
ALS May Be Best Treated With Combinations of Small Molecule Inhibitors & ASOs With Gene Therapy
A new clinical review entitled “Aberrant RNA homeostasis in amyotrophic lateral sclerosis: potential for new therapeutic targets?”,…
Cytokinetics Presents Latest Data on ALS Drug at International ALS Symposium
Clinical-stage biopharmaceutical company Cytokinetics presented their lead drug candidate for the treatment of amyotrophic lateral…
New Biotech Company Yumanity Launched to Treat Protein Misfolding Diseases, Like ALS
Yumanity Therapeutics, a new biotechnology company working on the development of drug discoveries for the treatment of conditions caused by protein misfolding, was launched…
Gene Mutations Still a Factor in ALS Patients Without Family History
According to a July 2014 report in the Morbidity and Mortality Weekly Report (MMWR), amytrophic lateral sclerosis…